Wed, Aug 5, 2015
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Morgan Stanley partners with Longchamp and La Française to provide investors with access to new alternative UCITS funds

Thursday, September 26, 2013
Opalesque Industry Update - Morgan Stanley today announced its partnership with Longchamp Asset Management (“Longchamp”), a French-based asset manager, specialising in the distribution of UCITS Hedge Funds, and La Française AM, a multispecialist asset manager with a ten year track record in alternative investments.

Through this collaboration, Morgan Stanley, Longchamp and La Française AM are leveraging their respective expertise to provide investors with access to new alternative UCITS Sub-Funds, through a joint selection and seeding arrangement with La Française AM. Currently, three funds have already been jointly selected and seeded by La Française AM under this partnership: the MS Turner Spectrum UCITS Fund, the MS Dalton Asia Pacific UCITS Fund and the MS TCW Unconstrained Plus Bond Fund.

“Our collaboration with Longchamp and La Française AM is an exciting venture for our Funds business. It provides us with the opportunity to expand our product range and offer investors access to a diverse range of strategies”, Stephane Berthet, Head of FundLogic Alternatives at Morgan Stanley, commented. “We are looking forward to this unique partnership and the benefits it can ultimately offer to our investors.” David Armstrong, President and Founder of Longchamp, added: “This venture with Morgan Stanley and La Française AM is an exciting opportunity. Morgan Stanley is the market leader in the UCITS alternatives space, with an unparalleled platform offering a diverse range of strategies, strong risk management and robust infrastructure.”

Patrick Riviere, Managing Director of La Française, commented: “La Française AM is a pioneer in terms of alternative investments. Ten years ago, we launched Alteram, a successful asset management company specialised in funds of hedge funds. Today we continue to believe in alternative investments as a perfect solution for investors as long as you can provide them with transparency, liquidity, and an attractive pricing. It’s exactly the aim of this partnership where La Française, alongside Morgan Stanley, is part of a seeding program. Within this strategic partnership La Française will be able to effectively leverage its competence and offer a new generation of alternative investments to its clients.”

FundLogic is the brand name for Morgan Stanley’s fund solutions platform launched in 2006. It offers both UCITS and non-UCITS funds. FundLogic, being part of Morgan Stanley’s Multi Asset Platform, delivers fund solutions to clients by combining the financial expertise, innovation and resources of Morgan Stanley, and offers a range of products including passive index funds, structured funds and the third party manager-UCITS funds.

Platform Details:
Platform Name: FundLogic
Umbrella Fund: FundLogic Alternatives Plc
Fund Domicile: Ireland
Number of Funds: 20
AUM $1.6bn (as of Sep-13)
Custodian: Northern Trust Fiduciary Services (Ireland) Limited
Administrator: Northern Trust International Fund Administration Services (Ireland) Ltd
Contact: fundlogic-ir@morganstanley.com

Press release

Recent related articles:
25.Mar.2013 Equinox and Morgan Stanley partner with Longchamp in the European regulated CTA sector
17.Apr.2013 NewApha and NExT AM may merge to create leading European business incubator
22.Jul.2013 Morgan Stanley launches Asia UCITS fund with Dalton Investments

Bg

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Activist News - Celgene says patent-fighting hedge fund manager wants to short its shares[more]

    From Reuters.com: Celgene Corp, one of the world's largest biotechnology companies, has accused U.S. hedge fund manager Kyle Bass of attempting to profit from his attempts to wipe out several major drug patents through his Coalition for Affordable Drugs. The company asked the U.S. Patent and T

  2. Einhorn's Greenlight Capital hedge fund slumps 6.1 percent in July[more]

    From Reuters/Thefiscaltimes.com: Hedge fund mogul David Einhorn's Greenlight Capital slumped 6.1 percent in July and is now down 9 percent for the year after gold, one of the fund's top holdings, tumbled to five-year lows last week. Greenlight notified clients of its returns late on Friday, ac

  3. Performance - Some hedge fund small-cap energy stocks have been free falling, Dan Loeb's simple strategy destroys the market, Baupost lost 1.4% last quarter as energy bargains proved elusive[more]

    Some hedge fund small-cap energy stocks have been free falling From Marketrealist.com: According to a July 28, 2015, Bloomberg article, there was a 34% fall in small-cap energy stocks over the past three months. These shares are tracked by the Russell 2000 Energy Index. Small-cap energy

  4. Legal - Hedge funds hit Rothstein Kass with $75m malpractice suit, JPMorgan questioned on private bank’s hedge fund disclosures, Kijani fund, seized by regulators in Cayman Islands, spotlights risks in lightly regulated market[more]

    Hedge funds hit Rothstein Kass with $75m malpractice suit From Law360.com: Two investment funds have sued Rothstein Kass & Co. PC for at least $75 million, claiming the New Jersey auditing firm committed accounting malpractice by failing to properly scrutinize overblown valuations of the

  5. Assets - Hedge funds are getting smoked by the commodities slump, Global ETF assets could more than double by 2020[more]

    Hedge funds are getting smoked by the commodities slump From Businessinsider.in: The collapse in commodity prices has burnt another hedge fund. Vermillion, a commodity hedge fund backed by Carlyle Group, has seen its flagship fund's assets fall from nearly $2 billion to less $50 million,

 

banner